These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 23073328)
1. Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Fujita H; Lennerz JK; Chung DC; Patel D; Deshpande V; Yoon SS; Lauwers GY Am J Surg Pathol; 2012 Nov; 36(11):1709-17. PubMed ID: 23073328 [TBL] [Abstract][Full Text] [Related]
2. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Shaw D; Blair V; Framp A; Harawira P; McLeod M; Guilford P; Parry S; Charlton A; Martin I Gut; 2005 Apr; 54(4):461-8. PubMed ID: 15753528 [TBL] [Abstract][Full Text] [Related]
3. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658 [TBL] [Abstract][Full Text] [Related]
4. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance. Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650 [TBL] [Abstract][Full Text] [Related]
5. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. Mi EZ; Mi EZ; di Pietro M; O'Donovan M; Hardwick RH; Richardson S; Ziauddeen H; Fletcher PC; Caldas C; Tischkowitz M; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2018 Feb; 87(2):408-418. PubMed ID: 28688938 [TBL] [Abstract][Full Text] [Related]
6. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Svrcek M Ann Pathol; 2011 Oct; 31(5):381-4. PubMed ID: 21982246 [No Abstract] [Full Text] [Related]
7. Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer? Munitiz Ruiz V; Jimeno P; Ruiz de Angulo D; Ortiz Á; Martínez de Haro LF; Marín M; Cascales P; Ruiz García G; Ortiz Ruiz E; Parrilla P Rev Esp Enferm Dig; 2019 Mar; 111(3):189-192. PubMed ID: 30466290 [TBL] [Abstract][Full Text] [Related]
8. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice? Zhang Q; Yang Z; Karamchandani DM Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421 [TBL] [Abstract][Full Text] [Related]
9. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lee CYC; Olivier A; Honing J; Lydon AM; Richardson S; O'Donovan M; Tischkowitz M; Fitzgerald RC; di Pietro M Lancet Oncol; 2023 Jan; 24(1):107-116. PubMed ID: 36509094 [TBL] [Abstract][Full Text] [Related]
10. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512 [TBL] [Abstract][Full Text] [Related]
11. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Lim YC; di Pietro M; O'Donovan M; Richardson S; Debiram I; Dwerryhouse S; Hardwick RH; Tischkowitz M; Caldas C; Ragunath K; Fitzgerald RC Gastrointest Endosc; 2014 Jul; 80(1):78-87. PubMed ID: 24472763 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations. Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689 [TBL] [Abstract][Full Text] [Related]
13. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome. Kumar S; Long JM; Ginsberg GG; Katona BW World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446 [TBL] [Abstract][Full Text] [Related]
14. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. Niemeyer E; Mofid H; Zornig C; Burandt EC; Stein A; Block A; Volk AE BMC Gastroenterol; 2020 May; 20(1):129. PubMed ID: 32362280 [TBL] [Abstract][Full Text] [Related]
15. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748 [TBL] [Abstract][Full Text] [Related]
16. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461 [No Abstract] [Full Text] [Related]
17. Random biopsies in patients harboring a CDH1 mutation: time to change the approach? Castro R; Lobo J; Pita I; Videira F; Pedro-Afonso L; Dinis-Ribeiro M; Brandão C Rev Esp Enferm Dig; 2020 May; 112(5):367-372. PubMed ID: 32338015 [TBL] [Abstract][Full Text] [Related]
18. Gastroscopic surveillance with targeted biopsies compared with random biopsies in CDH1 mutation carriers. van Dieren JM; Kodach LL; den Hartog P; van der Kolk LE; Sikorska K; van Velthuysen MF; van Sandick JW; Koemans WJ; Snaebjornsson P; Cats A Endoscopy; 2020 Oct; 52(10):839-846. PubMed ID: 32408363 [TBL] [Abstract][Full Text] [Related]